📣 VC round data is live. Check it out!
- Public Comps
- Pro-Dex
Pro-Dex Valuation Multiples
Discover Pro-Dex's revenue and EBITDA valuation multiples and M&A history, alongside public comparables like Huons Co, Utah Medical, Onward Medical, TriSalus Life Sciences and more.
Pro-Dex Overview
About Pro-Dex
Pro-Dex Inc designs, develops, manufactures, and sells powered surgical instruments for medical device original equipment manufacturers (OEMs) to various countries. Its product portfolio includes autoclavable, battery-powered, electric, and multi-function surgical drivers and shavers used mainly in orthopedic, thoracic, and craniomaxillofacial markets. The company also provides engineering, quality, regulatory consulting services, and manufactures rotary air motors utilized in various industries. Operating out of ISO-certified facilities in California, Pro-Dex serves hospitals, medical labs, and high-tech manufacturers, generating revenue through sales of surgical instruments and related services.
Founded
1994
HQ

Employees
181
Website
Financials (LTM)
EV
$221M
Valuation Multiples
Start free trialPro-Dex Financials
Pro-Dex reported last 12-month revenue of $76M.
In the same LTM period, Pro-Dex generated $13M in net income.
Revenue (LTM)
Pro-Dex P&L
In the most recent fiscal year, Pro-Dex reported revenue of $67M and EBITDA of $14M.
Pro-Dex is profitable as of last fiscal year, with gross margin of 29%, EBITDA margin of 21%, and net margin of 13%.
Financial data powered by Morningstar, Inc.
Pro-Dex Stock Performance
Pro-Dex has current market cap of $213M, and enterprise value of $221M.
Market Cap Evolution
Pro-Dex's stock price is $66.75.
Pro-Dex share price increased by 3.0% in the last 30 days, and by 53.0% in the last year.
Pro-Dex has an EPS (earnings per share) of $2.81.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $221M | $213M | -0.7% | 3.0% | 35.9% | 53.0% | $2.81 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialPro-Dex Valuation Multiples
Pro-Dex trades at 2.9x EV/Revenue multiple, and 15.7x EV/EBITDA.
EV / Revenue (LTM)
Pro-Dex Financial Valuation Multiples
As of June 4, 2026, Pro-Dex has market cap of $213M and EV of $221M.
Pro-Dex has a P/E ratio of 16.8x.
Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Pro-Dex Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.


Pro-Dex Margins & Growth Rates
Pro-Dex grew revenue by 15% and EBITDA by 1% in the last fiscal year.
In the most recent fiscal year, Pro-Dex reported gross margin of 29%, EBITDA margin of 21%, and net margin of 13%.
Pro-Dex Margins
Pro-Dex Growth Rates
Data powered by FactSet, Inc. and Morningstar, Inc.
Pro-Dex Operational KPIs
Pro-Dex's revenue per employee in the last FY averaged $0.4M, while opex per employee averaged $0.0M for the same period.
Pro-Dex's Rule of 40 is 28% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Pro-Dex's Rule of X is 43% (created by Bessemer, Rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
Data powered by FactSet, Inc. and Morningstar, Inc.
Pro-Dex Competitors
Pro-Dex competitors include Huons Co, Utah Medical, Onward Medical, TriSalus Life Sciences, RxSight, Ilex Medical, Asterasys, Treace Medical Concepts, Medinice and Lucid Diagnostics.
Most Pro-Dex public comparables operate across Medical Devices, DeepTech and HealthTech.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| Last FY | LTM | 2027E | Last FY | LTM | 2027E | |
| 0.7x | - | 5.2x | - | |||
| 3.3x | - | 8.8x | - | |||
| 26.3x | 15.7x | (3.6x) | (2.8x) | |||
| 4.0x | 3.7x | (11.1x) | (12.2x) | |||
| (0.0x) | (0.0x) | 0.1x | 0.0x | |||
| 0.4x | - | 3.3x | - | |||
| 7.5x | 6.3x | 22.7x | 18.2x | |||
| 1.2x | 1.2x | (62.9x) | (53.1x) | |||
This data is available for Pro users. Sign up to see all Pro-Dex competitors and their valuation data. Start Free Trial | ||||||
Acquisitions by Pro-Dex
Pro-Dex has acquired 1 company to date.
Last acquisition by Pro-Dex was on February 12th 2026. Pro-Dex acquired Advanced Precision Machining for $9M (EV/Revenue multiple available to Pro users).
Latest Acquisitions by Pro-Dex
| Description | Advanced Precision Machining produces custom precision components through machining and fabrication processes. The company caters to aerospace, defense, and medical sectors with high-tolerance parts from its US facilities. |
| HQ Country | |
| HQ City | - |
| Deal Date | 12 Feb 2026 |
| Valuation | $9M |
| EV/Revenue | |
| EV/EBITDA | |
This data is available for Pro users. Sign up to see all Pro-Dex acquisitions and their M&A valuation multiples. Start Free Trial | |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Pro-Dex
| Who are competitors of Pro-Dex? | Pro-Dex main competitors include Huons Co, Utah Medical, Onward Medical, TriSalus Life Sciences, RxSight, Ilex Medical, Asterasys, Treace Medical Concepts, Medinice, Lucid Diagnostics. |
See public comps similar to Pro-Dex
Lists including Pro-Dex
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.
